P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA

Introduction and Objectives: Hepatocellular carcinoma (HCC) is the sixth most frequent type of cancer and the fourth cause of death related to cancer worldwide. Remarkably, HCC is the most common type of liver cancer. According to the International Agency for Research on Cancer (IARC), the incidence...

Full description

Bibliographic Details
Main Authors: Adriana Varón, José Leonardo Pérez, Cristina Torres, Juan Manuel Pérez, José Gabriel Caviedes, Diego Piñeros, Gilberto Mejía, Jairo Rivera, Ciro Murcia, Geovanny Hernández, Martin Garzón, Oscar Beltrán
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268123001060
_version_ 1827981878527787008
author Adriana Varón
José Leonardo Pérez
Cristina Torres
Juan Manuel Pérez
José Gabriel Caviedes
Diego Piñeros
Gilberto Mejía
Jairo Rivera
Ciro Murcia
Geovanny Hernández
Martin Garzón
Oscar Beltrán
author_facet Adriana Varón
José Leonardo Pérez
Cristina Torres
Juan Manuel Pérez
José Gabriel Caviedes
Diego Piñeros
Gilberto Mejía
Jairo Rivera
Ciro Murcia
Geovanny Hernández
Martin Garzón
Oscar Beltrán
author_sort Adriana Varón
collection DOAJ
description Introduction and Objectives: Hepatocellular carcinoma (HCC) is the sixth most frequent type of cancer and the fourth cause of death related to cancer worldwide. Remarkably, HCC is the most common type of liver cancer. According to the International Agency for Research on Cancer (IARC), the incidence of liver cancer in Colombia was 2%, with a 4% mortality in 2020. This study aimed to describe the clinical characteristics of patients with HCC at a liver transplant center in Colombia in the period 2015 to 2020. Materials and Methods: Descriptive study of consecutive patients with HCC. We developed an HCC registry from our outpatient Clinic in which we reported clinical status, imaging, and therapeutic management. The continuous variables were described as the mean and standard deviation, and nominal variables were evaluated based on frequencies and percentages. All analyses were done in Statistical Package for the Social Sciences (SPPS) v. 21.0. Results: In total, 131 HCC patients were included, 76 men and 37 women, with an average age of 65 years. Of these patients, 40% were classified as CHILD PUGH (CP) - A, 42% were CP-B and in less proportion, 16.7% were CP-C. The etiology of the cirrhosis was diverse; most cases had a history of alcoholism (34%) and a past medical history of B and C viral infection (23.6%). The radiological characteristics of patients with HCC are shown in table 1. Therapeutic interventions assessed were radiofrequency ablation (ARF 61.6%), microwave ablation (AMO, 7.53%), transarterial chemoembolization (TACE, 30.8%) and liver transplant after ablative treatment (20.5%). Different outcomes analyzed were complete responses for ARF (52.2%), AMO (72.7%) and TACE (4.4%). Conclusions: In our historical cohort, liver function allowed the achievement of curative therapeutic interventions (ARF/AMO) with a complete response in more than 50% of patients intervened and 20% of patients taken for a liver transplant. Our results highlight the importance of premature detection of high-risk patients and early therapeutic interventions in this population of patients.
first_indexed 2024-04-09T22:14:53Z
format Article
id doaj.art-39f1ad1304824a6d924cf4a21255d0cc
institution Directory Open Access Journal
issn 1665-2681
language English
last_indexed 2024-04-09T22:14:53Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Annals of Hepatology
spelling doaj.art-39f1ad1304824a6d924cf4a21255d0cc2023-03-23T04:34:26ZengElsevierAnnals of Hepatology1665-26812023-03-0128101002P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIAAdriana Varón0José Leonardo Pérez1Cristina Torres2Juan Manuel Pérez3José Gabriel Caviedes4Diego Piñeros5Gilberto Mejía6Jairo Rivera7Ciro Murcia8Geovanny Hernández9Martin Garzón10Oscar Beltrán11Hepatology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaGastroenterology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaHepatology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaInterventional Radiology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaInterventional Radiology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaInterventional Radiology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaLiver Transplant Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaLiver Transplant Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaLiver Transplant Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaHepatology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaHepatology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaHepatology Department, LaCardio, Cardioinfantil Foundation. Bogotá, ColombiaIntroduction and Objectives: Hepatocellular carcinoma (HCC) is the sixth most frequent type of cancer and the fourth cause of death related to cancer worldwide. Remarkably, HCC is the most common type of liver cancer. According to the International Agency for Research on Cancer (IARC), the incidence of liver cancer in Colombia was 2%, with a 4% mortality in 2020. This study aimed to describe the clinical characteristics of patients with HCC at a liver transplant center in Colombia in the period 2015 to 2020. Materials and Methods: Descriptive study of consecutive patients with HCC. We developed an HCC registry from our outpatient Clinic in which we reported clinical status, imaging, and therapeutic management. The continuous variables were described as the mean and standard deviation, and nominal variables were evaluated based on frequencies and percentages. All analyses were done in Statistical Package for the Social Sciences (SPPS) v. 21.0. Results: In total, 131 HCC patients were included, 76 men and 37 women, with an average age of 65 years. Of these patients, 40% were classified as CHILD PUGH (CP) - A, 42% were CP-B and in less proportion, 16.7% were CP-C. The etiology of the cirrhosis was diverse; most cases had a history of alcoholism (34%) and a past medical history of B and C viral infection (23.6%). The radiological characteristics of patients with HCC are shown in table 1. Therapeutic interventions assessed were radiofrequency ablation (ARF 61.6%), microwave ablation (AMO, 7.53%), transarterial chemoembolization (TACE, 30.8%) and liver transplant after ablative treatment (20.5%). Different outcomes analyzed were complete responses for ARF (52.2%), AMO (72.7%) and TACE (4.4%). Conclusions: In our historical cohort, liver function allowed the achievement of curative therapeutic interventions (ARF/AMO) with a complete response in more than 50% of patients intervened and 20% of patients taken for a liver transplant. Our results highlight the importance of premature detection of high-risk patients and early therapeutic interventions in this population of patients.http://www.sciencedirect.com/science/article/pii/S1665268123001060
spellingShingle Adriana Varón
José Leonardo Pérez
Cristina Torres
Juan Manuel Pérez
José Gabriel Caviedes
Diego Piñeros
Gilberto Mejía
Jairo Rivera
Ciro Murcia
Geovanny Hernández
Martin Garzón
Oscar Beltrán
P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
Annals of Hepatology
title P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
title_full P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
title_fullStr P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
title_full_unstemmed P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
title_short P-118 HEPATOCELLULAR CARCINOMA. AN EXPERIENCE IN A TRANSPLANT CENTER IN COLOMBIA
title_sort p 118 hepatocellular carcinoma an experience in a transplant center in colombia
url http://www.sciencedirect.com/science/article/pii/S1665268123001060
work_keys_str_mv AT adrianavaron p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT joseleonardoperez p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT cristinatorres p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT juanmanuelperez p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT josegabrielcaviedes p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT diegopineros p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT gilbertomejia p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT jairorivera p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT ciromurcia p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT geovannyhernandez p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT martingarzon p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia
AT oscarbeltran p118hepatocellularcarcinomaanexperienceinatransplantcenterincolombia